Discontinuation of Levemir® (insulin detemir) FlexPen® and Penfill® - fact sheet for consumers
This fact sheet provides information about the discontinuation of Levemir® (insulin detemir) products in Australia. It aims to support consumers, their families and/or carers understand key considerations to safely transition to an alternative insulin therapy.
Downloads
Discontinuation of Levemir® (insulin detemir) FlexPen® and Penfill® - fact sheet for consumers
- For more information:
- Medicines shortages and discontinuations
- Publication Year:
- 2026
- Resource Type:
- Fact sheet
Accessibility: We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.
Copyright: Unless stated otherwise, materials provided are covered by a Creative Commons Attribution-Non-Commercial-No Derivatives (BY-NC-ND) 4.0 International License.
Request permission to reproduce material produced by the Commission by completing this form.